Cas no 1417887-91-2 (Stauntosaponin A)
Stauntosaponin A Chemical and Physical Properties
Names and Identifiers
-
- Stauntosaponin A
- Stauntoside C
- [ "Stauntoside C" ]
- HY-N1217
- 1417887-91-2
- CS-0016604
- (2R,3R,4R,6R)-6-[[(1R,4R,5R,8S,16S,19S,22R)-5,19-dimethyl-15,18,20-trioxahexacyclo[14.5.1.01,14.04,13.05,10.019,22]docosa-9,11,13-trien-8-yl]oxy]-4-methoxy-2-methyloxan-3-ol
- AKOS032962709
-
- Inchi: 1S/C28H38O7/c1-15-23(29)20(30-4)12-22(33-15)34-17-7-9-26(2)16(11-17)5-6-18-19(26)8-10-28-14-32-27(3)24(28)21(13-31-27)35-25(18)28/h5-6,11,15,17,19-24,29H,7-10,12-14H2,1-4H3/t15-,17+,19+,20-,21-,22+,23-,24-,26+,27-,28+/m1/s1
- InChI Key: KNFHQIUXHMJLPI-IXHFUHRASA-N
- SMILES: O1C2=C3C=CC4=C[C@H](CC[C@]4(C)[C@H]3CC[C@]32CO[C@]2(C)[C@H]3[C@H]1CO2)O[C@H]1C[C@H]([C@@H]([C@@H](C)O1)O)OC
Computed Properties
- Exact Mass: 486.26200
- Monoisotopic Mass: 486.26175355g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 35
- Rotatable Bond Count: 3
- Complexity: 1000
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 11
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 75.6
- XLogP3: 2.4
Experimental Properties
- Color/Form: Powder
- Density: 1.3±0.1 g/cm3
- Boiling Point: 658.8±55.0 °C at 760 mmHg
- Flash Point: 352.2±31.5 °C
- PSA: 75.61000
- LogP: 3.62080
- Vapor Pressure: 0.0±4.5 mmHg at 25°C
Stauntosaponin A Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ℃, better at -4 ℃
Stauntosaponin A Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN5060-1 mg |
Stauntosaponin A |
1417887-91-2 | 1mg |
¥2835.00 | 2022-04-26 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S49400-5 mg |
Stauntosaponin A |
1417887-91-2 | 5mg |
¥5600.0 | 2021-09-07 | ||
| A2B Chem LLC | AE61019-5mg |
Stauntosaponin A |
1417887-91-2 | 5mg |
$869.00 | 2024-04-20 | ||
| TargetMol Chemicals | TN5060-5 mg |
Stauntosaponin A |
1417887-91-2 | 98% | 5mg |
¥ 4,890 | 2023-07-10 | |
| TargetMol Chemicals | TN5060-1 mL * 10 mM (in DMSO) |
Stauntosaponin A |
1417887-91-2 | 98% | 1 mL * 10 mM (in DMSO) |
¥ 4990 | 2023-09-15 | |
| TargetMol Chemicals | TN5060-5mg |
Stauntosaponin A |
1417887-91-2 | 5mg |
¥ 15800 | 2024-07-19 |
Stauntosaponin A Related Literature
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
Additional information on Stauntosaponin A
Exploring the Potential of Stauntosaponin A (CAS No. 1417887-91-2): A Comprehensive Overview
Stauntosaponin A (CAS No. 1417887-91-2) is a naturally occurring saponin compound that has garnered significant attention in recent years due to its potential therapeutic and industrial applications. As a member of the saponin family, Stauntosaponin A exhibits unique chemical properties that make it a subject of interest for researchers and industries alike. This article delves into the molecular structure, biological activities, and emerging applications of this fascinating compound.
The molecular structure of Stauntosaponin A features a triterpenoid aglycone core with sugar moieties attached, which contributes to its amphiphilic nature and biological activity. This structural characteristic is shared with other bioactive saponins, but Stauntosaponin A stands out due to its specific sugar configuration and unique pharmacological profile. Researchers have identified several potential health benefits associated with this compound, including antioxidant, anti-inflammatory, and immune-modulating properties.
In the context of current health trends, Stauntosaponin A aligns with the growing demand for natural bioactive compounds in nutraceuticals and functional foods. Consumers are increasingly searching for "natural immune boosters" and "plant-derived bioactive compounds," making Stauntosaponin A particularly relevant. The compound's potential to support immune function without synthetic additives positions it as an attractive ingredient for health-conscious consumers.
The cosmetic industry has also shown interest in Stauntosaponin A due to its skin-beneficial properties. As consumers search for "natural skincare ingredients" and "plant-based actives," this compound offers potential applications in anti-aging formulations and skin barrier enhancement products. Its ability to interact with skin cell membranes may contribute to improved delivery of other active ingredients, making it valuable for advanced cosmetic formulations.
From a research perspective, Stauntosaponin A (CAS No. 1417887-91-2) presents exciting opportunities in drug discovery. Scientists investigating "natural product drug leads" and "novel therapeutic saponins" are particularly interested in its molecular targets and mechanism of action. Preliminary studies suggest potential applications in metabolic disorders and cellular health, though further clinical research is needed to validate these effects.
The extraction and purification of Stauntosaponin A present technical challenges that researchers are actively addressing. Current methods focus on optimizing yield while maintaining the compound's structural integrity. As sustainability becomes a key concern in natural product sourcing, researchers are exploring "green extraction techniques" for Stauntosaponin A to minimize environmental impact.
In agricultural applications, Stauntosaponin A shows promise as a natural alternative to synthetic compounds. The growing interest in "sustainable agriculture" and "biopesticides" has led to investigations into its potential as a plant growth regulator or natural pest deterrent. These applications align with global trends toward reducing synthetic chemical use in farming.
Quality control and standardization of Stauntosaponin A preparations remain important considerations for commercial applications. Analytical methods such as HPLC and LC-MS are commonly used to characterize and quantify the compound in various matrices. These quality assurance measures ensure consistency in research and product development involving this bioactive molecule.
The market potential for Stauntosaponin A is growing alongside increasing consumer awareness of natural health products. Industry analysts tracking "natural ingredient markets" and "bioactive compound trends" have noted rising interest in specialized saponins like Stauntosaponin A. This trend is particularly strong in regions with established nutraceutical and traditional medicine industries.
Future research directions for Stauntosaponin A (CAS No. 1417887-91-2) include detailed pharmacokinetic studies, mechanism of action elucidation, and potential synergistic effects with other bioactive compounds. As scientific understanding of this molecule grows, so too will its potential applications across multiple industries, from healthcare to agriculture and beyond.
For researchers and industry professionals seeking reliable information about Stauntosaponin A, it's important to consult peer-reviewed studies and reputable suppliers. The compound's unique properties and growing body of research make it an exciting area of study in the field of natural product chemistry and its various applications.
1417887-91-2 (Stauntosaponin A) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)